{
  "label": "clinical_signal_03_ep_014",
  "artifact_type": "signal_episode",
  "artifact_id": "sha256:b08218ce3d02ccfe9ecbf36edf52c0b3413259f3c751bf58bb4075281fed8607",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:54:45.742288",
  "content": "## 2024-06-03 Daily Operations Summary\n\n### Enrollment\n- Total Randomized: 192\n- Active: 182\n- Screen Failures Cumulative: 28\n- Withdrawals Cumulative: 10\n\n### Sites\n- Site 01\n  - Enrolled: 19\n  - Active: 19\n  - Statin Concomitant: 5\n- Site 02\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 4\n- Site 03\n  - Enrolled: 18\n  - Active: 18\n  - Statin Concomitant: 4\n- Site 04\n  - Enrolled: 13\n  - Active: 13\n  - Statin Concomitant: 3\n- Site 05\n  - Enrolled: 16\n  - Active: 16\n  - Statin Concomitant: 5\n- Site 06\n  - Enrolled: 11\n  - Active: 11\n  - Statin Concomitant: 3\n- Site 07\n  - Enrolled: 21\n  - Active: 21\n  - Statin Concomitant: 6\n- Site 08\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 3\n- Site 09\n  - Enrolled: 16\n  - Active: 16\n  - Statin Concomitant: 5\n- Site 10\n  - Enrolled: 13\n  - Active: 13\n  - Statin Concomitant: 4\n- Site 11\n  - Enrolled: 18\n  - Active: 18\n  - Statin Concomitant: 5\n- Site 12\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 3\n\n### Lab Panels\n- Statin Subgroup\n  - N: 53\n  - ALT (U/L) Mean: 57.6\n  - ALT (U/L) Median: 56.0\n  - AST (U/L) Mean: 45.7\n  - AST (U/L) Median: 45.7\n  - Bilirubin (mg/dL) Mean: 0.86\n  - Bilirubin (mg/dL) Median: 0.83\n  - ALP (U/L) Mean: 65.4\n  - ALP (U/L) Median: 57.0\n  - Creatinine (mg/dL) Mean: 0.89\n  - Creatinine (mg/dL) Median: 0.85\n  - BUN (mg/dL) Mean: 14.7\n  - BUN (mg/dL) Median: 13.1\n  - WBC (K) Mean: 6.2\n  - WBC (K) Median: 7.0\n  - Platelets (K) Mean: 223\n  - Platelets (K) Median: 223\n- Non-Statin Subgroup\n  - N: 124\n  - ALT (U/L) Mean: 29.4\n  - ALT (U/L) Median: 27.5\n  - AST (U/L) Mean: 26.6\n  - AST (U/L) Median: 25.1\n  - Bilirubin (mg/dL) Mean: 0.43\n  - Bilirubin (mg/dL) Median: 0.41\n  - ALP (U/L) Mean: 74.1\n  - ALP (U/L) Median: 70.2\n  - Creatinine (mg/dL) Mean: 0.98\n  - Creatinine (mg/dL) Median: 0.96\n  - BUN (mg/dL) Mean: 17.8\n  - BUN (mg/dL) Median: 12.4\n  - WBC (K) Mean: 7.7\n  - WBC (K) Median: 6.6\n  - Platelets (K) Mean: 259\n  - Platelets (K) Median: 226\n\n### Adverse Events\n- AE ID: AE-0045\n  - Description: upper respiratory infection\n  - Grade: 1\n  - Relatedness: not related\n  - Resolved: true\n  - Subject Group: non_statin\n- AE ID: AE-0046\n  - Description: back pain\n  - Grade: 1\n  - Relatedness: not related\n  - Resolved: true\n  - Subject Group: non_statin\n- AE ID: AE-0047\n  - Description: diarrhea\n  - Grade: 1\n  - Relatedness: possibly related\n  - Resolved: true\n  - Subject Group: non_statin\n- AE ID: AE-0048\n  - Description: transaminase measurement out of range\n  - Grade: 1\n  - Relatedness: possibly related\n  - Resolved: true\n  - Subject Group: statin\n- AE ID: AE-0049\n  - Description: abdominal discomfort\n  - Grade: 1\n  - Relatedness: possibly related\n  - Resolved: true\n  - Subject Group: statin\n\n### Concomitant Meds\n- Statin Count: 55\n- ACE Inhibitor Count: 28\n- Metformin Count: 21\n- PPI Count: 19\n- NSAID Count: 12\n- Other Count: 36\n\n### Protocol Deviations\n- PD ID: PD-029\n  - Description: Blood draw outside protocol-specified fasting window\n  - Severity: minor\n  - Site: site_06\n- PD ID: PD-030\n  - Description: Lab sample mislabeled, corrected same day\n  - Severity: minor\n  - Site: site_02\n\n### Investigator Notes\n- Lab kits inventory adequate for next 4 weeks\n- Subject retention rate within protocol targets\n- EDC data entry backlog cleared, queries resolved\n\n### Events\n- CRO quarterly oversight report submitted\n- Medical monitor weekly call completed\n- Central lab courier pickup schedule adjusted for holiday\n- Site 07: ALT analyzer service notification, recalibration pending\n\n### Notes\n- Week 14: Site 07 ALT analyzer flagged for recalibration. Statin subgroup ALT values at 1.5-2x ULN.",
  "metadata": {
    "episode_id": "clinical_signal_03_ep_014",
    "scope_id": "clinical_signal_03",
    "timestamp": "2024-06-03T10:00:00",
    "phase": "early_signal",
    "signal_density": "low",
    "episode_type": "signal",
    "layer_name": "signal_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "724335e48952198659b608a79f591f6985cc457d1b0726c271a193e4d218a284",
      "components": {
        "transform": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
        "inputs": "a94b84fbaca9bd62"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
      "components": {
        "transform_id": "cb4ddfa83a38701b",
        "source": "42e76241d396a578",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}